Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 177 526 184 765 194 579 252 523 256 217 264 365
EBITDA 13 053 12 522 12 734 17 709 18 287 19 047
Operating profit (EBIT) 10 578 10 043 10 255 15 026 15 029 15 764
Pre-Tax Profit (EBT) 8 637 8 268 1 406 8 803 10 889 11 086
Net income 5 317 6 622 -594 6 593 7 454 8 056
P/E ratio 16,1x 11,3x -115x 12,1x 10,7x 10,0x
EPS ( $ ) 4,90 6,44 -0,57 5,07 5,74 6,14
Dividend per Share ( $ ) 1,70 2,00 2,00 1,99 1,99 2,03
Yield 2,15% 2,76% 3,05% 3,24% 3,24% 3,30%
Reference price ( $ ) 78,910 72,500 65,520 61,390 61,390 61,390
Announcement Date 02/09/2017
11:58am
02/08/2018
11:55am
02/20/2019
11:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 24 073 25 195 66 848 62 460 56 272 48 049
Finance - - - - - -
Operating income (EBITDA) 13 053 12 522 12 734 17 709 18 287 19 047
Leverage
(Debt/EBITDA)
1,84x 2,01x 5,25x 3,53x 3,08x 2,52x
Capital Expenditure 2 224 1 918 2 037 2 494 2 588 2 666
Book Value Per Share (BVPS) ( $ ) 34,7 37,2 55,8 53,3 57,7 62,6
Cash Flow per Share ( $ ) 9,33 7,82 8,49 8,16 8,77 9,28
Announcement Date 02/09/2017
11:58am
02/08/2018
11:55am
02/20/2019
11:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 79 837 M $ -
Entreprise Value (EV) 142 297 M $ 136 109 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 12,1x 10,7x
Capitalization / Revenue 0,32x 0,31x
EV / Revenue 0,56x 0,56x
EV / EBITDA 8,04x 7,78x
Yield (DPS / Price) 3,24% 3,24%
Price to book (Price / BVPS) 1,15x 1,06x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 5,95% 5,87%
Operating Leverage (Delta EBIT / Delta Sales) 1,56x 0,01x
Net Margin (Net Profit / Revenue) 2,61% 2,91%
ROA (Net Profit / Asset) 4,29% 4,90%
ROE (Net Profit / Equities) 13,7% 13,6%
Rate of Dividend 39,3% 34,7%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,99% 1,01%
Cash Flow / Sales 4,20% 4,45%
Capital Intensity (Assets / Sales) 0,61x 0,59x
Financial Leverage (Net Debt / EBITDA) 3,53x 3,08x
EPS & Dividend